Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
20 November 2024
Sales revenues for October 2024
30 October 2024
Notification according to Art. 89t of the LPOS concerning an increase of the capital of "Sopharma" AD by exercising warrants from the issue ISIN BG9200001212
25 October 2024
Notification on the terms and conditions for distribution of the dividend voted at the Extraordinary General Meeting of Shareholders of "Sopharma" AD held on October 25, 2024
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
29 November 2024
Consolidated financial statements for Q3 of 2024
20 December 2024
Financial revenues for January-November 2024

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A